Discovery and characterization of new original blocking antibodies targeting the CD73 immune checkpoint for cancer immunotherapy

被引：4
|
作者：
Paoli, Marc Giraudon
Augier, Severine
Blemont, Marilyne Royannez
Rodriguez, Celine
Blanc, Helene Rispaud
Chanteux, Stephanie
Gourdin, Nicolas
Gauthier, Laurent
Caux, Christine Menetrier
Morel, Yannis
Caux, Christophe
Paturel, Carine
Perrot, Ivan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2344
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2344
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Discovery of AB680: A potent and selective CD73 inhibitor for cancer immunotherapy
    Lawson, Kenneth
    Kalisiak, Jarek
    Lindsey, Erick
    Newcomb, Eric
    Sharif, Ehesan
    Miles, Dillon
    Jeffrey, Jenna
    Leleti, Manmohan Reddy
    Chen, Ada
    Jin, Lixia
    Tan, Joanne
    Schindler, Uli
    Young, Steve
    Jaen, Juan
    Powers, Jay
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [22] Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
    Tang, Tianyu
    Huang, Xing
    Zhang, Gang
    Hong, Zhengtao
    Bai, Xueli
    Liang, Tingbo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [23] Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy
    Tianyu Tang
    Xing Huang
    Gang Zhang
    Zhengtao Hong
    Xueli Bai
    Tingbo Liang
    Signal Transduction and Targeted Therapy, 6
  • [24] Improvement of agonist cancer immunotherapy by CD73 blockade
    Chen, Siqi
    Fan, Jie
    Zhang, Minghui
    Qin, Lei
    Dominguez, Donye
    Long, Alan
    Zhang, Bin
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [25] The impact of CD73 immune checkpoint blockade on procoagulant tissue factor
    Garrad, Evan
    Panicker, Sumith
    Moitra, Jaideep
    Kanthi, Yogen
    VASCULAR MEDICINE, 2023, 28 (05) : 506 - 506
  • [26] The CD73 immune checkpoint promotes tumor cell metabolic fitness
    Allard, David
    Cousineau, Isabelle
    Ma, Eric H.
    Allard, Bertrand
    Bareche, Yacine
    Fleury, Hubert
    Stagg, John
    ELIFE, 2023, 12
  • [27] Discovery and characterization of AB680, a potent and selective small-molecule CD73 inhibitor for cancer immunotherapy
    Lawson, Kenneth V.
    Jin, Lixia
    Jeffrey, Jenna L.
    Kalisiak, Jarek
    Yin, Fangfang
    Zhang, Kristen
    Chen, Ada
    Swinarski, Debbie
    Walters, Matt J.
    Young, Steve
    Schindler, Ulrike
    Jay, Powers P.
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Discovery and characterization of potent and selective small-molecule inhibitors of ecto-nucleotidase CD73 for cancer immunotherapy
    Lawson, K.
    Kalisiak, J.
    Lindsey, E.
    Newcomb, E.
    Rosen, B.
    Walker, N.
    Jin, L.
    Scaletti, E.
    Strater, N.
    Chen, A.
    Tan, J.
    Walters, M. J.
    Young, S.
    Schindler, U.
    Leleti, M.
    Powers, J. P.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E93 - E93
  • [29] Discovery and preclinical characterization of INCA00186, a humanized monoclonal antibody antagonist of CD73, as a cancer immunotherapy.
    Stewart, Shaun
    Buonpane, Rebecca
    Zhou, Jing
    Hansbury, Michael
    Smith, Michael
    Wang, Hui
    Lu, Lu
    Su, Bin
    Awdew, Rahel
    Huang, Cheng-Yen
    Kulkarni, Ashwini
    Harvey, Shane
    Mondal, Arpita
    Wang, Steve
    Stevens, Christina
    Pratta, Michael
    Behshad, Elham
    Fanuka, Alexandra
    Ren, Xiaodi
    Koblish, Holly
    Nastri, Horacio
    Mayes, Patrick
    CANCER RESEARCH, 2021, 81 (13)
  • [30] Discovery and characterization of potent and selective small-molecule inhibitors of ecto-nucleotidase CD73 for cancer immunotherapy
    Sharif, Ehesan
    Lawson, Kenneth
    Kalisiak, Jarek
    Lindsey, Erick
    Newcomb, Eric
    Rosen, Brandon
    Walker, Nigel
    Jin, Lixia
    Scaletti, Emma
    Straeter, Norbert
    Chen, Ada
    Leleti, Manmohan Reddy
    Powers, Jay
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
12345